References
- Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 1998; 21(4): 518–24
- Brown AF, Mangione CM, Saliba D, et al; California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders With Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51(5 Suppl Guidelines): S265–80
- American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005; 28 Suppl 1: S4–36 [Erratum, Diabetes Care 2005; 28(4): 990]
- Kimmel B, Inzucchi SE. Oral agents for type 2 diabetes: an update. Clin Diabetes 2005; 23: 64–76
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group, lancet 1998; 352(9131): 837–53 [Erratum, Lancet 1999; 354(9178): 602]
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352(9131): 854–65 [Erratum, Lancet 1998; 352(9139): 1557]
- Salpeter SR, Greyber E, Pasternak GA, et al. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 2003; 163(21): 2594–602
- Masoudi FA, Inzucchi SE, Wang Y, et al. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation 2005; 111(5): 583–90
- Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 2004; 351(11): 1106–18
- Nesto RW, Bell D, Bonow RO, et al; American Heart Association; American Diabetes Association. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Oct 7, 2003. Circulation 2003; 108(23): 2941–8
- Dailey GE III. Early insulin: an important therapeutic strategy. Diabetes Care 2005; 28(1): 220–1
- Riddle MC, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003; 26(11): 3080–6